Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Anders Jack Create: Alert

All | News | Filings
Date FiledTypeDescription
03/21/2023 4 Anders Jack (CFO) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Sold 665 shares @ $21.78, valued at $14.5k
12/21/2022 4 Anders Jack (CFO) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Sold 658 shares @ $22.9405, valued at $15.1k
09/21/2022 4 Anders Jack (CFO) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Sold 449 shares @ $19.0426, valued at $8.6k
09/02/2022 4 Anders Jack (CFO) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Granted 10,000 shares @ $0
Granted 35,000 options to buy @ $21.61, valued at $756.4k
06/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/21/2021 4 Anders Jack (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Sold 166 shares @ $30.02, valued at $5k
06/22/2021 4 Anders Jack (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Sold 160 shares @ $34.1241, valued at $5.5k
03/08/2021 4 Anders Jack (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Granted 7,400 shares @ $0
Granted 25,900 options to buy @ $42.45, valued at $1.1M
10/15/2020 4 Anders Jack (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Sold 10,000 shares @ $44, valued at $440k
Exercised 10,000 options to buy @ $2.68, valued at $26.8k
10/08/2020 4 Anders Jack (See Remarks) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Sold 10,000 shares @ $40, valued at $400k
Exercised 10,000 options to buy @ $2.68, valued at $26.8k
02/12/2020 3 Anders Jack (See Remarks) has filed a Form 3 on Revolution Medicines, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy